Abstract: The invention relates to a composition for a bone substitute that includes powdery or populated porous bio-glass and powdery alpha hemihydrate calcium sulphate. The invention also relates to an injectable composition for forming a bone substitute that includes said composition of powdery or granulated porous bio-glass and powdery alpha hemihydrate calcium sulphate, with 10 to 50 wt % of added water.

Abstract: The invention relates to porous bioglass and to the preparation method thereof. More specifically, the invention relates to a solid, porous crystalline or partially-crystalline composition containing at least SiO2, Ca<SB>O</SB>, Na2O, and P2O5, comprising micropores and macropores. The invention is characterised in that: the pore ratio varies between 50% and 80%, preferably between 60 and 75%, and is measured using the geometric method; the average diameter of the macropores varies between 100 and 1250 micrometers, preferably between 150 and 300 micrometers; the average diameter of the micropores is less than or equal to 5 micrometers; and the compression strength varies between 7 MPa and 70 MPa. The invention also relates to the method of preparing one such composition and to such a composition treated with a physiological liquid having an ionic composition similar to that of human plasma. The invention also relates to an implant which is made from one such composition.

Abstract: The invention relates to a method for preparing a composite material having a homogeneous composition, containing at least one bioactive ceramic phase and at least one bioresorbable polymer. The inventive method is characterised in that it comprises the following steps: a) a bioactive ceramic phase in powder form is obtained, b) the bioactive ceramic powder is suspended in a solvent, c) a bioresorbable polymer is added to the suspension obtained in (b) and mixed to produce a viscous homogeneous dispersion of said bioactive ceramic powder in a solution formed by the solvent and the polymer, and d) the dispersion obtained in (c) is precipitated in an aqueous solution in order to obtain a homogeneous composite material. The invention also relates to the resulting composite material and to the use thereof in the production of implantable medical devices.

Abstract: The invention relates to porous bioglass and to the preparation method thereof. More specifically, the invention relates to a solid, porous crystalline or partially-crystalline composition containing at least SiO2, Ca<SB>O</SB>, Na2O, and P2O5, comprising micropores and macropores. The invention is characterised in that: the pore ratio varies between 50% and 80%, preferably between 60 and 75%, and is measured using the geometric method; the average diameter of the macropores varies between 100 and 1250 micrometers, preferably between 150 and 300 micrometers; the average diameter of the micropores is less than or equal to 5 micrometers; and the compression strength varies between 7 MPa and 70 MPa. The invention also relates to the method of preparing one such composition and to such a composition treated with a physiological liquid having an ionic composition similar to that of human plasma. The invention also relates to an implant which is made from one such composition.